Cargando…
Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120022/ https://www.ncbi.nlm.nih.gov/pubmed/34047472 http://dx.doi.org/10.1002/ctm2.420 |
| _version_ | 1783691979138269184 |
|---|---|
| author | Yun, Jae Won Lee, Sejoon Chun, Sejong Lee, Kwang Woo Kim, Jongsu Kim, Hong Sook |
| author_facet | Yun, Jae Won Lee, Sejoon Chun, Sejong Lee, Kwang Woo Kim, Jongsu Kim, Hong Sook |
| author_sort | Yun, Jae Won |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8120022 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81200222021-05-21 Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer Yun, Jae Won Lee, Sejoon Chun, Sejong Lee, Kwang Woo Kim, Jongsu Kim, Hong Sook Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-05-13 /pmc/articles/PMC8120022/ /pubmed/34047472 http://dx.doi.org/10.1002/ctm2.420 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Yun, Jae Won Lee, Sejoon Chun, Sejong Lee, Kwang Woo Kim, Jongsu Kim, Hong Sook Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer |
| title | Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer |
| title_full | Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer |
| title_fullStr | Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer |
| title_full_unstemmed | Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer |
| title_short | Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer |
| title_sort | comprehensive analysis of oncogenic signatures and consequent repurposed drugs in tmprss2:erg fusion‐positive prostate cancer |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120022/ https://www.ncbi.nlm.nih.gov/pubmed/34047472 http://dx.doi.org/10.1002/ctm2.420 |
| work_keys_str_mv | AT yunjaewon comprehensiveanalysisofoncogenicsignaturesandconsequentrepurposeddrugsintmprss2ergfusionpositiveprostatecancer AT leesejoon comprehensiveanalysisofoncogenicsignaturesandconsequentrepurposeddrugsintmprss2ergfusionpositiveprostatecancer AT chunsejong comprehensiveanalysisofoncogenicsignaturesandconsequentrepurposeddrugsintmprss2ergfusionpositiveprostatecancer AT leekwangwoo comprehensiveanalysisofoncogenicsignaturesandconsequentrepurposeddrugsintmprss2ergfusionpositiveprostatecancer AT kimjongsu comprehensiveanalysisofoncogenicsignaturesandconsequentrepurposeddrugsintmprss2ergfusionpositiveprostatecancer AT kimhongsook comprehensiveanalysisofoncogenicsignaturesandconsequentrepurposeddrugsintmprss2ergfusionpositiveprostatecancer |